Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson's disease

Amino Acids

Volumn 42, Issue 2-3, 2012, Pages 775-781

  Condello, Salvatore ^a   Calabrò, Emanuele ^b   Caccamo, Daniela ^a   Currò, Monica ^a   Ferlazzo, Nadia ^a   Satriano, Joseph ^c   Magazù, Salvatore ^b   Ientile, Riccardo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agmatine; Fourier transform infrared spectroscopy; Membrane mitochondrial potential; Neuroprotection; Reactive oxygen species; SH SY5Y neuroblastoma cells

Indexed keywords

AGMATINE; AMIDE; AMIDE I; AMIDE II; ROTENONE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIOXIDANT ACTIVITY; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CELL DAMAGE; CELL LEVEL; CELL PROTECTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; HUMAN; HUMAN CELL; HYDROGEN BOND; INFRARED SPECTROSCOPY; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN FOLDING; BIOLOGICAL MODEL; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

AGMATINE; CELL LINE, TUMOR; HUMANS; MODELS, BIOLOGICAL; NEUROBLASTOMA; PARKINSON DISEASE; ROTENONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84861693017     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0994-z     Document Type: Article

References (35)

1. Agostinelli E, Marques MP, Calheiros R, Gil FP, Tempera G, Viceconte N, Battaglia V, Grancara S, Toninello A (2010) Polyamines: fundamental characters in chemistry and biology. Amino Acids 38:393-403
2. Ahn SK, Hong S, Park YM, Lee WT, Park KA, Lee JE (2011) Effects of agmatine on hypoxic microglia and activity of nitric oxide synthase. Brain Res 1373:48-54
3. Arndt MA, Battaglia V, Parisi E et al (2009) The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis. Am J Physiol Cell Physiol 296:C1411-C1419
4. Barth A (2000) The infrared absorption of amino acid side chains. Prog Biophys Mol Biol 74:141-173 (Pubitemid 32168153)
5. Battaglia V, Grancara S, Satriano J, Saccoccio S, Agostinelli E, Toninello A (2010) Agmatine prevents the Ca(2+)-dependent induction of permeability transition in rat brain mitochondria. Amino Acids 38:431-437
6. Ben-Shachar D, Riederer P, Youdim MB (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J Neurochem 57:1609-1614 (Pubitemid 21922796)
7. Calabrò E, Magazù S (2010) Inspections of mobile phone microwaves effects on proteins secondary structure by means of Fourier transform infrared spectroscopy. J Electromag Anal Appl 2:607-617
8. Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK (2010) Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One 5(8):e12333
9. Condello S, Currò M, Ferlazzo N, Caccamo D, Satriano J, Ientile R (2011) Agmatine effects on mitochondrial membrane potential and NF-jB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. J Neurochem 116:67-75
10. Cuervo AM, Wong ES, Martinez-Vicente M (2010) Protein degradation, aggregation, and misfolding. Mov Disord 25:S49-S54
11. Di Giambattista L, Grimaldi P, Gaudenzi S, Pozzi D, Grandi M, Morrone S, Silvestri I, Congiu Castellano A (2010) UVB radiation induced effects on cells studied by FTIR spectroscopy. Eur Biophys J 39:929-934
12. Fabian H, Vogel HJ (2002) Fourier transform infrared spectroscopy of calcium-binding proteins. Methods Mol Biol 173:57-74
13. Fabian H, Schultz C, Naumann D, Landt O, Hahn U, Saenger WJ (1993) Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. Mol Biol 232:967-981
14. Galloway PG, Mulvihill P, Perry G (1992) Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 140:809-822
15. Giasson BI, Lee VM (2001) Parkin and the molecular pathways of Parkinson's disease. Neuron 31:885-888 (Pubitemid 32925276)
16. Gilad GM, Gilad VH, Finberg JP, Rabey JM (2005) Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity. Neurochem Res 30:713-719 (Pubitemid 41413930)
17. Higgins DS, Greenamyre JT (1996) [H-3]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. J Neurosci 16:3807-3816 (Pubitemid 26176045)
18. Hong S, Lee JE, Kim CY, Seong GJ (2007) Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci 8:81
19. Iizuka Y, Hong S, Kim CY, Kim SK, Seong GJ (2008) Agmatine pretreatment protects retinal ganglion cells (RGC-5 cell line) from oxidative stress in vitro. Biocell 32:245-250
20. Ismail AA, Mantch HH, Wong PTT (1992) Aggregation of chymotrypsinogen: portrait by infrared spectroscopy. Biochim Biophys Acta 1121:183-188
21. Jackson M, Mantsch HH (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev Biochem Mol Biol 30:95-120
22. Kang SY, Wasaka T, Shamim EA, Auh S, Ueki Y, Lopez GJ, Kida T, Jin SH, Dang N, Hallett M (2010) Characteristics of the sequence effect in Parkinson's disease. Mov Disord 25: 2148-2155
23. Kim HY, Chung JM, Chung K (2008) Increased production of mitochondrial superoxide in the spinal cord induces pain behaviors in mice: the effect of mitochondrial electron transport complex inhibitors. Neurosci Lett 447:87-91
24. Kong J, Yu S (2007) Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin 39:549-559 (Pubitemid 47293710)
25. Lefevre T, Subirade M (2000) Molecular differences in the formation and structure of fine-stranded and particulate b-lactoglobulin gels. Biopolymers 54:578-586
26. Marshall LE, Himes RH (1978) Rotenone inhibition of tubulin selfassembly. Biochim Biophys Acta 543:590-594
27. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163:1450-1455 (Pubitemid 19244751)
28. Morley JF, Hurtig HI (2010) Current understanding and management of Parkinson disease: five new things. Neurology 75:S9-S15
29. Ren Y, Zhao J, Feng J (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci 23:3316-3324 (Pubitemid 36531973)
30. Roberts JC, Grocholski BM, Kitto KF, Fairbanks CA (2005) Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J Pharmacol Exp Ther 314:1226-1233 (Pubitemid 41205988)
31. Schapira AH (2006) Etiology of Parkinson's disease. Neurology 66:S10-S23
32. Smith BM, Franzen S (2002) Single-pass attenuated total reflection Fourier transform infrared spectroscopy for the analysis of proteins in H2O. Sol Anal Chem 74:4076-4080 (Pubitemid 34912907)
33. Surewicz WK, Mantsch HH (1988) New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochim Biophys Acta 952:115-130 (Pubitemid 18027334)
34. Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 123:1086-1092
35. Zhang G, Moore DJ, Flach CR, Mendelsohn R (2007) Vibrational microscopy and imaging of skin: from single cells to intact tissue. Anal Bioanal Chem 387:1591-1599